Skip to content
CELG Stock Analysis with Charles Duncan episode artwork

Jun 26, 2008 1 min

CELG Stock Analysis with Charles Duncan

from BioBusiness.TV, the podcast! ver2 Hosted by BioBusiness.TV / Charles Duncan, Managing Director and Senior Biotechnology Analyst, JMP Securities / Daniel Teper, Managing Director at Bionest Partners, and Founder & Chairman of BioBusiness.TV

You are Watching: Celgene's Revlimid, Markets and Revenues, with Charles Duncan. What are the next areas of growth for Revlimid? Asides from the growth in frontline use for Multiple Myeloma, Charles Duncan tells us about its use in Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). Revlimid is also bound to expand its geographical reach with Europe and Japan. Charles' expectation is that Revlimid will be a $2.8+ billion opportunity drug. Finally, he explains Revlimid's contribution to Celgene's bottom line and stock price. Charles' price target for CELG is $85. This interview was conducted at the NASDAQ Marketsite, on June 26th, 2008, in New York City. Featuring: * Charles Duncan, Managing Director and Senior Biotechnology Analyst, JMP Securities * Daniel Teper, Managing Director at Bionest Partners, and Founder & Chairman of BioBusiness.TV DISCLAIMER: BIOBUSINESS.TV IS AN INDEPENDENT MEDIA, AND A PLATFORM FOR THE EXCHANGE OF IDEAS AND OPINIONS. BIOBUSINESS.TV STRIVES TO ENHANCE THE QUALITY AND ACCESSIBILITY OF INDUSTRY DATA, AND TO DELIVER INFORMATION THAT INVESTORS AND EXECUTIVES CAN RELY UPON TO MAKE SOUND, INFORMED FINANCIAL AND MANAGERIAL DECISIONS. VIEWERS SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

CELG Stock Analysis with Charles Duncan

0:00 1:15

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of BioBusiness.TV, the podcast! ver2?

This episode is 1 minute long.

When was this BioBusiness.TV, the podcast! ver2 episode published?

This episode was published on June 26, 2008.

Can I download this BioBusiness.TV, the podcast! ver2 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.